Saturday, May 11 2024
11:15 AM – 11:30 AM ET - Room 307-308
398: CSF Delivery of INS1201 AAV9-Micro-Dystrophin Demonstrates Efficacy in a Mouse Model of DMD
Gretchen Thomsen
Insmed Gene Therapy
Disclosures: G. Thomsen: 1; Commercial Interest i.e. Company X; Insmed Gene Therapy. 1; What was received? i.e. Honorarium; Salary, stocks, stock options. 1; For what role? i.e. Speaker; Employment.
Related Abstract